Publication | Open Access

Induction therapy with vincristine, adriamycin, dexamethasone (VAD) and intermediate-dose melphalan (IDM) followed by autologous or allogeneic stem cell transplantation in newly diagnosed multiple myeloma

Hematological MalignancyTransplantationMarrow TransplantationMedicineHematologyImmunologyMyeloid NeoplasiaMultiple MyelomaBlood TransplantationIntermediate-dose MelphalanRadiation OncologyOncologyCell TransplantationInduction TherapyHealth Sciences